Acne vulgaris, a widespread inflammatory dermatosis of the pilosebaceous unit, is one of the most prevalent skin concerns globally. In the United States alone, it affects approximately 50 million individuals annually. While traditionally associated with adolescents, this condition extends into adulthood, impacting individuals in their 20s and 30s. Acne constitutes the primary reason for seeking dermatological treatment, with over 85% of adolescents and young adults aged 12 to 24 years experiencing some degree of acne, and its incidence among adults continues to rise. Notably, over 90% of acne cases are classified as mild to moderate.